Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.96 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.96 |
| ▸ | HRH1 | P35367 | 2/20 | 0.68 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | TBXAS1 | P24557 | 7/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.57 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6115279 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6114977 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6114843 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25381701 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL919570 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25381172 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25380936 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL25382598 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL6115248 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 | |
| SCHEMBL4461304 | 1.00 | TDP1 (0.96) | TDP1L3MBTL1HRH1CYP2A6TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100347864-C | Photoelectric conversion film, storage type device and display using the same | COMPAL ELECTRONICS INC (CN) | 2007-11-07 | — | — | CN | claimed |
| CN-1570713-A | Photoelectric conversion film, storage type device and display using the same | COMPAL ELECTRONICS INC (CN) | 2005-01-26 | — | — | CN | claimed |
| CN-116323712-B | Alkali releasing composition and curable resin composition using same | 纳美仕有限公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20230399550-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING THE SAME | NAMICS CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| EP-4239025-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME | Namics Corporation (JP) | 2023-09-06 | — | — | EP | disclosed |
| CN-116323712-A | Alkali releasing composition and curable resin composition using same | 纳美仕有限公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2022091989-A1 | BASE-RELEASING COMPOSITION AND CURABLE RESIN COMPOSITION USING SAME | ナミックス株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-20150174145-A1 | Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action | CORREIA PEDRO BRITO (PT) | 2015-06-25 | — | — | US | disclosed |
| CN-103281904-A | Method of controlling harmful arthropod, composition, and electrostatic spray device | SUMITOMO CO LTD | 2013-09-04 | — | — | CN | disclosed |
| CN-103079408-A | Pest controlling method, composition, electrostatic spray device and use thereof | SUMITOMO CHEMICAL CO | 2013-05-01 | — | — | CN | disclosed |
| CN-103037908-A | Method and composition for delivering active ingredient into air, and use thereof | SUMITOMO CHEMICAL CO | 2013-04-10 | — | — | CN | disclosed |
| CN-100347864-C | Photoelectric conversion film, storage type device and display using the same | COMPAL ELECTRONICS INC (CN) | 2007-11-07 | — | — | CN | disclosed |
| CN-1570713-A | Photoelectric conversion film, storage type device and display using the same | COMPAL ELECTRONICS INC (CN) | 2005-01-26 | — | — | CN | disclosed |
| EP-0288515-B1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | ISP INVESTMENTS INC. (US) | 1993-05-05 | — | — | EP | disclosed |
| EP-0288515-A4 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | — | 1990-09-26 | — | — | EP | disclosed |
| US-4883655-A | HAIR OR SKIN CONDITIONING | GAF CORPORATION (US) | 1989-11-28 | — | — | US | disclosed |
| EP-0288515-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS. | GAF CORP (US) | 1988-11-02 | — | — | EP | disclosed |
| WO-1988002985-A1 | QUATERNIZED NITROGEN CONTAINING COMPOUNDS | GAF CORPORATION (US) | 1988-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150174145-A1 | Pharmaceutical compounds with the structure of ionic salts with antibiotic and anticancer action | ABCC1, SLC11A2, CFTR | TDP1 3581/4885L3MBTL1 2963/4885HRH1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.